Company attributes
B2X
CEO
Founder
AngelList URL
Pitchbook URL
Number of Employees (Ranges)
11 – 50
Full Address
150 2ND St Cambridge, MA, 02141-2115 United States
Investors
Founded Date
2016
Latest Funding Round Date
December 1, 2016
Latest Funding Type
Wellfound ID
Other attributes
Company Operating Status
Active
Founded in 2014 and headquartered in San Francisco, California, LexentBio focuses on the development of liquid biopsy technology for applications in cancer treatment and diagnostics.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
